secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2023-01-11T23:59:59+00:00
Accession:  0001104659-23-003041
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Brainstorm Cell Therapeutics annual meeting elects directors and ratifies auditor
--------------------------------------------------------------------------------

- Seven nominees elected to Board: Arbel, Almenoff, Polverino, Frenkel, Taub, Yablonka, Bairu; each received >10M votes for.
- Ratification of Brightman Almagor Zohar & Co. (Deloitte) as auditor approved: 23.3M for, 482K against, 66K abstentions.
- Virtual meeting held January 10, 2023; broker non-votes of 13.1M on director elections.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465923003041/0001104659-23-003041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465923003041/tm232977d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-003041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer